PapersFlow Research Brief
Gynecological conditions and treatments
Research Guide
What is Gynecological conditions and treatments?
Gynecological conditions and treatments encompass the clinical management, diagnostic approaches, and reproductive outcomes of disorders such as endometriosis, uterine leiomyomas, endometrial polyps, Asherman syndrome, Müllerian duct anomalies, and intrauterine adhesions, often involving hysteroscopic interventions and hormonal therapies.
This field includes 55,938 works focused on uterine anomalies and related conditions like congenital uterine abnormalities and Asherman syndrome. Key aspects cover diagnostic hysteroscopy and hysteroscopic treatments for intrauterine adhesions alongside developmental genetics of the female reproductive tract. Growth data over the past five years is not available.
Topic Hierarchy
Research Sub-Topics
Congenital Uterine Anomalies
This sub-topic addresses classification, prevalence, and reproductive impacts of Müllerian duct anomalies like unicornuate or bicornuate uteri. Researchers study diagnostic imaging and fertility outcomes using ESHRE/ESGE systems.
Asherman Syndrome Management
Focuses on intrauterine adhesions causing Asherman syndrome, including hysteroscopic adhesiolysis techniques and recurrence prevention. Studies evaluate postoperative estrogen therapy and second-look hysteroscopy.
Endometrial Polyps and Hysteroscopy
Examines diagnostic hysteroscopy, polypectomy outcomes, and polyp recurrence risks in abnormal uterine bleeding. Research covers histopathological features and impact on implantation in IVF.
Hysteroscopic Treatment of Intrauterine Adhesions
This area studies advanced hysteroscopic techniques for severe adhesions, including barrier devices and stem cell therapies. Outcomes assess adhesion reformation and live birth rates.
Developmental Genetics of Müllerian Ducts
Investigates genetic regulation of female reproductive tract development, focusing on HOX genes, WNT signaling, and animal models. Studies link mutations to human uterine anomalies.
Why It Matters
Endometriosis affects about 10% of reproductive-age women, causing symptoms including severe pain, dysmenorrhea, dyspareunia, dysuria, infertility, and fatigue, with hormonal therapy controlling symptoms in some cases while surgery is required for others (Zondervan et al. (2020) "Endometriosis"). Uterine leiomyomas show a high cumulative incidence detected by ultrasound in black and white women (Baird et al. (2003) "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence"). Vaginal hysterectomy outperforms laparoscopic and abdominal approaches for benign gynecological disease, enabling faster return to normal activities and fewer postoperative febrile episodes (Aarts et al. (2015) "Surgical approach to hysterectomy for benign gynaecological disease"). These treatments directly influence reproductive outcomes and quality of life in affected patients.
Reading Guide
Where to Start
"Endometriosis" by Zondervan et al. (2020) because it provides a clear overview of prevalence, symptoms, and basic treatment options including hormonal therapy and surgery for reproductive-age women.
Key Papers Explained
Zondervan et al. (2020) "Endometriosis" and Giudice (2010) "Endometriosis" establish core symptoms and evaluation for endometriosis, building to Dunselman et al. (2014) "ESHRE guideline: management of women with endometriosis" for structured management. Baird et al. (2003) "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence" adds epidemiology of related uterine conditions, while Aarts et al. (2015) "Surgical approach to hysterectomy for benign gynaecological disease" details surgical preferences. Classifications in American Society for Reproductive Medicine (1997) "Revised American Society for Reproductive Medicine classification of endometriosis: 1996" and the 1988 American Fertility Society paper provide diagnostic frameworks.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus remains on refining hysteroscopic treatments for intrauterine adhesions and Müllerian anomalies, with classifications from older high-citation works like the 1988 American Fertility Society paper guiding current diagnostics. No recent preprints or news available indicate steady reliance on established guidelines such as Dunselman et al. (2014).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Revised American Society for Reproductive Medicine classificat... | 1997 | Fertility and Sterility | 2.9K | ✕ |
| 2 | Dating the Endometrial Biopsy | 1950 | Fertility and Sterility | 2.9K | ✕ |
| 3 | High cumulative incidence of uterine leiomyoma in black and wh... | 2003 | American Journal of Ob... | 2.4K | ✕ |
| 4 | ESHRE guideline: management of women with endometriosis | 2014 | Human Reproduction | 2.2K | ✓ |
| 5 | Endometriosis | 2020 | New England Journal of... | 1.9K | ✕ |
| 6 | Endometriosis | 2010 | New England Journal of... | 1.9K | ✕ |
| 7 | Endometriosis: pathogenesis and treatment | 2013 | Nature Reviews Endocri... | 1.8K | ✕ |
| 8 | The American Fertility Society classifications of adnexal adhe... | 1988 | Fertility and Sterility | 1.8K | ✕ |
| 9 | Surgical approach to hysterectomy for benign gynaecological di... | 2015 | Cochrane Database of S... | 1.8K | ✓ |
| 10 | EPIDEMIOLOGY OF ENDOMETRIOSIS | 1997 | Obstetrics and Gynecol... | 1.6K | ✕ |
Frequently Asked Questions
What is the prevalence of endometriosis?
Endometriosis affects about 10% of reproductive-age women. Symptoms include severe pain, dysmenorrhea, dyspareunia, dysuria, infertility, and fatigue. Hormonal therapy controls symptoms in some women, while others require surgery (Zondervan et al. (2020) "Endometriosis").
How is endometriosis managed according to guidelines?
The ESHRE guideline addresses management of women with endometriosis (Dunselman et al. (2014) "ESHRE guideline: management of women with endometriosis"). Hormonal therapy controls symptoms in some patients, and surgery may be needed though not always effective (Zondervan et al. (2020) "Endometriosis"). Evaluation includes assessing dysmenorrhea, dyspareunia, and pain as in a 25-year-old patient case (Giudice (2010) "Endometriosis").
What are the advantages of vaginal hysterectomy?
Vaginal hysterectomy is superior to laparoscopic and abdominal hysterectomy for benign disease, with faster return to normal activities and fewer febrile episodes postoperatively. It should be preferred when technically feasible (Aarts et al. (2015) "Surgical approach to hysterectomy for benign gynaecological disease"). This applies to conditions like uterine leiomyomas.
How is the endometrial biopsy dated?
Dating the endometrial biopsy is a standard method in gynecological assessment (Noyes et al. (1950) "Dating the Endometrial Biopsy"). It aids in evaluating conditions affecting the endometrium such as polyps or adhesions.
What classifications exist for endometriosis and related anomalies?
The Revised American Society for Reproductive Medicine classification of endometriosis was updated in 1996 (American Society for Reproductive Medicine (1997) "Revised American Society for Reproductive Medicine classification of endometriosis: 1996"). The American Fertility Society provides classifications for adnexal adhesions, tubal occlusion, Müllerian anomalies, and intrauterine adhesions (1988) "The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions").
What is the epidemiology of uterine leiomyomas?
Ultrasound evidence shows high cumulative incidence of uterine leiomyoma in black and white women (Baird et al. (2003) "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence"). This informs screening and treatment strategies.
Open Research Questions
- ? What is the exact pathogenesis of endometriosis given its unclear mechanisms?
- ? How can surgical outcomes for intrauterine adhesions be optimized beyond current hysteroscopic approaches?
- ? What genetic factors drive developmental anomalies in the female reproductive tract across mammals?
- ? Why do hormonal therapies succeed in some endometriosis patients but fail in others requiring surgery?
- ? How does the incidence of uterine leiomyomas vary by ethnicity beyond ultrasound detection?
Recent Trends
The field maintains 55,938 works with no specified five-year growth rate.
High-citation papers from 1950 to 2020 dominate, including Zondervan et al. "Endometriosis" noting 10% prevalence.
2020No recent preprints or news coverage in the last 12 months reported.
Research Gynecological conditions and treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Gynecological conditions and treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers